You are here

  • Home
  • Archive
  • Volume 53, Issue 9
  • Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis

Article info

Article menu
Download PDFPDF
Cancer genetics
Original article
Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis

Authors

  • Ranjit Manchanda Barts Cancer Institute, Queen Mary University of London, London, UK Department of Women's Cancer, Gynaecological Cancer Research Centre, Institute for Women's Health, University College London, London, UK Department of Gynaecological Oncology, St Bartholomew's Hospital, London, UK PubMed articlesGoogle scholar articles
  • Rosa Legood Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK PubMed articlesGoogle scholar articles
  • Antonis C Antoniou Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK PubMed articlesGoogle scholar articles
  • Vladimir S Gordeev Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK PubMed articlesGoogle scholar articles
  • Usha Menon Department of Women's Cancer, Gynaecological Cancer Research Centre, Institute for Women's Health, University College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ranjit Manchanda, Barts Cancer Institute, Queen Mary University of London, Old Anatomy Building, Charterhouse Square, London EC1M 6BQ, UK; r.manchanda{at}ucl.ac.ukProf Usha Menon, Department of Women’s Cancer, Institute for Women’s Health, University College London, London W1T 7DN, UK u.menon{at}ucl.ac.uk
View Full Text

Citation

Manchanda R, Legood R, Antoniou AC, et al
Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis
Journal of Medical Genetics 2016;53:591-599.

Publication history

  • Received January 25, 2016
  • Revised March 17, 2016
  • Accepted April 1, 2016
  • First published June 27, 2016.
Online issue publication 
June 29, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/